1. Home
  2. LAB vs CPAC Comparison

LAB vs CPAC Comparison

Compare LAB & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • CPAC
  • Stock Information
  • Founded
  • LAB 1999
  • CPAC 1949
  • Country
  • LAB United States
  • CPAC Peru
  • Employees
  • LAB 818
  • CPAC N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • CPAC Building Materials
  • Sector
  • LAB Industrials
  • CPAC Industrials
  • Exchange
  • LAB Nasdaq
  • CPAC Nasdaq
  • Market Cap
  • LAB 504.2M
  • CPAC 580.5M
  • IPO Year
  • LAB 2011
  • CPAC 2012
  • Fundamental
  • Price
  • LAB $1.30
  • CPAC $7.14
  • Analyst Decision
  • LAB Buy
  • CPAC Hold
  • Analyst Count
  • LAB 2
  • CPAC 1
  • Target Price
  • LAB $2.50
  • CPAC $6.40
  • AVG Volume (30 Days)
  • LAB 1.2M
  • CPAC 7.4K
  • Earning Date
  • LAB 10-29-2025
  • CPAC 10-27-2025
  • Dividend Yield
  • LAB N/A
  • CPAC 7.08%
  • EPS Growth
  • LAB N/A
  • CPAC 26.68
  • EPS
  • LAB N/A
  • CPAC 0.14
  • Revenue
  • LAB $172,271,000.00
  • CPAC $572,828,408.00
  • Revenue This Year
  • LAB N/A
  • CPAC N/A
  • Revenue Next Year
  • LAB N/A
  • CPAC N/A
  • P/E Ratio
  • LAB N/A
  • CPAC $9.70
  • Revenue Growth
  • LAB 76.33
  • CPAC 3.37
  • 52 Week Low
  • LAB $0.92
  • CPAC $5.10
  • 52 Week High
  • LAB $2.32
  • CPAC $7.32
  • Technical
  • Relative Strength Index (RSI)
  • LAB 48.53
  • CPAC 60.84
  • Support Level
  • LAB $1.25
  • CPAC $6.85
  • Resistance Level
  • LAB $1.38
  • CPAC $7.31
  • Average True Range (ATR)
  • LAB 0.07
  • CPAC 0.22
  • MACD
  • LAB -0.00
  • CPAC -0.02
  • Stochastic Oscillator
  • LAB 26.83
  • CPAC 74.99

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: